185 related articles for article (PubMed ID: 25222591)
21. The use of intravenous magnesium in non-preeclamptic pregnant women: fetal/neonatal neuroprotection.
Jacquemyn Y; Zecic A; Van Laere D; Roelens K
Arch Gynecol Obstet; 2015 May; 291(5):969-75. PubMed ID: 25501980
[TBL] [Abstract][Full Text] [Related]
22. Maternal side effects & fetal neuroprotection according to body mass index after magnesium sulfate in a multicenter randomized controlled trial.
Vilchez G; Dai J; Lagos M; Sokol RJ
J Matern Fetal Neonatal Med; 2018 Jan; 31(2):178-183. PubMed ID: 28056569
[TBL] [Abstract][Full Text] [Related]
23. School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo.
Doyle LW; Anderson PJ; Haslam R; Lee KJ; Crowther C;
JAMA; 2014 Sep; 312(11):1105-13. PubMed ID: 25226476
[TBL] [Abstract][Full Text] [Related]
24. Blunted fetal response to vibroacoustic stimulation associated with maternal intravenous magnesium sulfate therapy.
Sherer DM
Am J Perinatol; 1994 Nov; 11(6):401-3. PubMed ID: 7857429
[TBL] [Abstract][Full Text] [Related]
25. Timing of administration of antenatal magnesium sulfate and umbilical cord blood magnesium levels in preterm babies.
Reynolds A; Slattery S; Byrne S; Neary E; Müllers S; Kent E; Malone FD; El-Khuffash A; McGarvey C; Hayes BC
J Matern Fetal Neonatal Med; 2019 Mar; 32(6):1014-1019. PubMed ID: 29082790
[TBL] [Abstract][Full Text] [Related]
26. Maternal magnesium therapy, neonatal serum magnesium concentration and immediate neonatal outcomes.
Narasimhulu D; Brown A; Egbert NM; Rojas M; Haberman S; Bhutada A; Minkoff H; Rastogi S
J Perinatol; 2017 Dec; 37(12):1297-1303. PubMed ID: 28981078
[TBL] [Abstract][Full Text] [Related]
27. Outcomes in twin pregnancies reduced to singleton pregnancies compared with ongoing twin pregnancies.
Gupta S; Fox NS; Feinberg J; Klauser CK; Rebarber A
Am J Obstet Gynecol; 2015 Oct; 213(4):580.e1-5. PubMed ID: 26071922
[TBL] [Abstract][Full Text] [Related]
28. Adverse maternal and neonatal outcome of prolonged course of magnesium sulfate tocolysis.
Nassar AH; Sakhel K; Maarouf H; Naassan GR; Usta IM
Acta Obstet Gynecol Scand; 2006; 85(9):1099-103. PubMed ID: 16929415
[TBL] [Abstract][Full Text] [Related]
29. Recurrence risk of preterm birth in subsequent singleton pregnancy after preterm twin delivery.
Schaaf JM; Hof MH; Mol BW; Abu-Hanna A; Ravelli AC
Am J Obstet Gynecol; 2012 Oct; 207(4):279.e1-7. PubMed ID: 22917487
[TBL] [Abstract][Full Text] [Related]
30. Proximity of magnesium exposure to delivery and neonatal outcomes.
Turitz AL; Too GT; Gyamfi-Bannerman C
Am J Obstet Gynecol; 2016 Oct; 215(4):508.e1-6. PubMed ID: 27177525
[TBL] [Abstract][Full Text] [Related]
31. A follow up on the feasibility after national implementation of magnesium sulfate for neuroprotection prior to preterm birth.
Hellström S; Jonsdotter A; Jonsson M; Pettersson K; Saltvedt S; Herbst A; Ågren J; Ådén U; Domellöf M; Hagberg H; Carlsson Y
Acta Obstet Gynecol Scand; 2023 Dec; 102(12):1741-1748. PubMed ID: 37680134
[TBL] [Abstract][Full Text] [Related]
32. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?
Nelson KB; Grether JK
Pediatrics; 1995 Feb; 95(2):263-9. PubMed ID: 7838646
[TBL] [Abstract][Full Text] [Related]
33. Intrapartum magnesium for prevention of cerebral palsy: continuing controversy?
Cahill AG; Stout MJ; Caughey AB
Curr Opin Obstet Gynecol; 2010 Apr; 22(2):122-7. PubMed ID: 20179596
[TBL] [Abstract][Full Text] [Related]
34. Outcomes Associated With Hypertensive Disorders of Pregnancy in Twin Compared With Singleton Gestations.
Aviram A; Berger H; Abdulaziz KE; Barrett JFR; Murray-Davis B; McDonald SD; Geary M; Melamed N;
Obstet Gynecol; 2021 Sep; 138(3):449-458. PubMed ID: 34352849
[TBL] [Abstract][Full Text] [Related]
35. Maternal obesity in singleton versus twin gestations: a population-based matched case-control study.
Lucovnik M; Blickstein I; Verdenik I; Trojner-Bregar A; Tul N
J Matern Fetal Neonatal Med; 2015 Apr; 28(6):623-5. PubMed ID: 24866350
[TBL] [Abstract][Full Text] [Related]
36. Magnesium sulfate for neuroprotection in the setting of chorioamnionitis.
Edwards JM; Edwards LE; Swamy GK; Grotegut CA
J Matern Fetal Neonatal Med; 2018 May; 31(9):1156-1160. PubMed ID: 28395549
[TBL] [Abstract][Full Text] [Related]
37. Immediate clinical outcomes in preterm neonates receiving antenatal magnesium for neuroprotection.
Basu SK; Chickajajur V; Lopez V; Bhutada A; Pagala M; Rastogi S
J Perinat Med; 2011 Aug; 40(2):185-9. PubMed ID: 21834608
[TBL] [Abstract][Full Text] [Related]
38. Prenatal Therapy with Magnesium Sulfate and Its Correlation with Neonatal Serum Magnesium Concentration.
García Alonso L; Pumarada Prieto M; González Colmenero E; Concheiro Guisán A; Suárez Albo M; Durán Fernández-Feijoo C; González Durán L; Fernández Lorenzo JR
Am J Perinatol; 2018 Jan; 35(2):170-176. PubMed ID: 28854447
[TBL] [Abstract][Full Text] [Related]
39. Antenatal Magnesium and Cerebral Palsy in Preterm Infants.
Hirtz DG; Weiner SJ; Bulas D; DiPietro M; Seibert J; Rouse DJ; Mercer BM; Varner MW; Reddy UM; Iams JD; Wapner RJ; Sorokin Y; Thorp JM; Ramin SM; Malone FD; Carpenter MW; O'Sullivan MJ; Peaceman AM; Hankins GD; Dudley D; Caritis SN;
J Pediatr; 2015 Oct; 167(4):834-839.e3. PubMed ID: 26254839
[TBL] [Abstract][Full Text] [Related]
40. Neonatal serum magnesium concentrations are determined by total maternal dose of magnesium sulfate administered for neuroprotection.
Borja-Del-Rosario P; Basu SK; Haberman S; Bhutada A; Rastogi S
J Perinat Med; 2014 Mar; 42(2):207-11. PubMed ID: 24006314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
